Julia G. Butchko

CIK 1796290 · Chief Development Officer · last filed 2024-08-23

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$14.83M

Companies

2

Total Filings

32

Lifetime Open-Market Net

-$2.53M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
IMVT	Chief Development Officer	441,079	$33.62	$14.83M	-$2.53M	30	2024-08-23
Immunovant, Inc. (IMVTW) Delisted	Chief Dev. & Tech. Officer	—	—	—	$0	2	2020-05-18

Recent Filings · Page 3 of 4

32 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2022-07-29	IMVT	Sell (S)	−510	-$2.2K	EDGAR
2022-07-01	IMVT	Sell (S)	−460	-$1.8K	EDGAR
2022-05-25	IMVT	Sell (S)	−492	-$1.9K	EDGAR
2022-04-29	IMVT	Sell (S)	−541	-$2.6K	EDGAR
2022-04-14	IMVT	Sell (S)	−6,381	-$37.6K	EDGAR
2022-01-11	IMVT	Sell (S)	−55,318	-$401.1K	EDGAR
2021-09-14	IMVT	Mixed	—	$0	EDGAR
2021-08-04	IMVT	Grant (A)	+285,306	$0	EDGAR
2021-03-23	IMVT	Grant (A)	+54,500	$0	EDGAR
2020-09-15	IMVT	Buy (P)	+5,000	$190.8K	EDGAR

Showing 21–30 of 32

Prev Page 3 of 4 Next

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.